Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Pfizer logo

  • Science
    • Clinical Trials
      • Guide to Clinical Trials
      • Clinical Trials in Children
      • Data and Results
      • Integrity and Transparency
      • Diversity
      • Plain Language Study Results
      • Expanded Access & Compassionate Use
    • Find a Trial
    • Areas of Focus
      • Internal Medicine
      • Inflammation & Immunology
      • Vaccines
      • Oncology
    • Diseases & Conditions
    • Product Pipeline
    • Research Sites
  • Products
    • How Drugs are Made
      • Branded vs. Generic
      • Biologics & Biosimilars
      • Commitment to Quality
      • Global Supply
      • Manufacturing Sites
    • Medicine Safety
      • Health Literacy
      • Treatment Choices
      • Partnering With Patients
      • Tips for Patients
      • Reporting Adverse Events
      • Counterfeiting
      • Product Safety
    • Product List
    • Product Contacts
    • PfizerForAll
    • PfizerPro for Professionals
    • Patient Assistance Programs
    • Distributors
      • Pfizer Distributors
  • Stories
    • Articles
    • Behind the Science Features
    • Scientist Stories
    • Patient Stories
    • Colleague Stories
    • Podcasts
  • Newsroom
    • Press Releases
    • Media Asset Library
    • Updates and Statements
    • Partnering News
    • Media Contacts
  • About
    • People
      • Executives
      • Board Members
    • Responsibility
      • Ethics & Compliance
      • Responsible Business
      • Patient Advocacy & Engagement
      • Global Impact
      • Diversity, Equity, and Inclusion
      • Environmental Sustainability
      • Human Rights
      • Health & Safety
      • Intellectual Property
      • EHS Governance
      • Misinformation
      • Antimicrobial Resistance
      • Animals Used in Research
      • Stem Cell Research Policy
    • Programs & Policies
      • Grants
      • Political Partnership
      • Working with Healthcare Professionals
      • Prescription Value & Pricing
      • Privacy Principles
      • Ready for Cures
      • Transparency in Grants
      • Policy Positions
    • Investors
      • Investors Overview
      • Why Invest
      • Events & Presentations
      • Financial Reports
      • Investor News
      • Stock Information
      • Shareholder Services
    • Corporate Governance
      • Corporate Governance Overview
      • Board Committees & Charters
      • The Pfizer Board Policies
      • Corporate Governance FAQs
      • Contact Our Directors
    • Purpose
    • History
    • Careers
    • Partners
      • Research and Business Development Partnerships
      • Venture Investments
      • Business to Business
      • Pfizer CentreOne
      • Submit Your Opportunities
Investors Media Careers Partners
Contact Us
  • Careers
  • Investors
Contact Us
0 search results for
Suggestions within Pfizer.com
  • Health Equity
  • Partnerships
  • Responsibility

2024 Health Equity in Action Summit: Communities Forward

Share

The Collective_heia_Summit Page Hero Image

“We’re in a moment of unprecedented progress, an ever-expanding movement to achieve racial and health equity,” stated Dr. Gail Christopher, Executive Director of the National Collaborative for Health Equity, as she kicked off her keynote at the second Health Equity in Action Summit: Communities Forward.

This two-day, hybrid event, held October 23-24, 2024, brought together a cross-sector of public health professionals, advocacy leaders, policymakers, and community-based organizations to learn from past programs, initiatives, and policies exposing existing gaps in the healthcare system and to help create sustainable solutions which seek to advance health equity for historically marginalized and underrepresented communities in the U.S.

Convened by Pfizer’s Multicultural Health Equity Collective (The Collective), Morehouse School of Medicine, National Association of County and City Health Officials, the National Caucus of Native American State Legislators, and The Century Foundation, the Summit emphasized the importance of engaging the next generation of health leaders. It focused on the essential role of communities in addressing health inequities. Day 1 brought together students and health equity leaders to learn, mentor, and network. Day 2 focused on exploring community-led solutions and creating a space for health equity experts to share diverse perspectives.

The Summit was held in Oklahoma in part to elevate the voices of Native and Indigenous communities. Home to 39 sovereign tribal nations, comprising about 13 percent of Oklahoma’s population, Summit conveners acknowledged and honored the Indigenous communities, including leaders from the Cherokee and Osage nations, who welcomed this event on their land, Native and Indigenous communities were invited to share their stories and health equity challenges, contributing additional insight on systemic issues that affect underrepresented communities.

Rising Leaders in Health

Exposing students and young leaders from diverse backgrounds to careers in health is critical to help strengthen our healthcare system and creating a more representative workforce able to respond to patient needs. That is why the Summit hosted upper high school, college, and medical students to hear more from healthcare professionals about career pathways in health and foster mentorship opportunities.

image of Eric Griggs
“Listen to that little voice in your mind, in your DNA, that tells you who you really are and who you can be. Always listen to that voice.”

— Dr. Eric Griggs, Vice Chair, 100 Black Men of America

“We all have a health equity story – you have one too, you may just not know it yet.”

— Michellene Davis, Esq., President & CEO, National Medical Fellowships

Image of Michellene Davis

Communities Forward

While health disparities have persisted for decades, community-based organizations have been at the forefront of fostering change. The Summit conveners sought to uplift these organizations driving systemic change to help close gaps in care and improve access for communities most impacted by health inequities.

Image of Bobby Pourier
“It is my lifelong commitment and goal to be able to provide the home that I had to other communities and to other families on my reservation. That’s been my steering compass.”

— Bobby Pourier, Summer Director, Pathway Program, Young Medicine Movement

“Achieving our goal in health equity is complex and long-term. By continuing to work together, we can create change.”

— Melissa Bishop-Murphy, JD, Senior Director, State Government Relations, Pfizer

Image of Melissa Bishop Murphy

Cross-sector leaders from across the U.S. joined to collaborate and learn from one another. They shared knowledge around successful efforts, explored challenges and highlighted learnings to create meaningful change. Several themes emerged from the conversation, including:

  1. Addressing systemic racism in healthcare delivery: Health biases and systemic racism can insidiously infiltrate the health systems that are meant to serve communities equitably. Systemic racism can impact the quality of care provided. It must be actively recognized and dismantled from decision- and policy-making. This includes ensuring that historically marginalized and underserved communities are represented at all levels of decision making, and promoting culturally competent care, such as offering services in various languages and considering the impact of social determinants of health.
  2. Ensuring fair research and data practices: Data and AI have become major topics of discussion across industries and Summit attendees examined fair data collection and use, transparency in reporting, and the importance of eliminating bias from data systems and AI outputs. Integrating these methods into research and analysis ensures the accuracy of data to help understand community health and help tailor health programs to successfully treat diverse populations.
  3. Centering lived experiences in changing health policies. Healthcare research and data help influence lifechanging health policies. However, in a time of increased polarization, panelists reflected on the importance of going beyond the data and lifting community voices, both to improve programs and advocate for change. Regardless of industry or focus, health equity leaders in this work all agreed that incorporating community perspectives and elevating the voices of historically marginalized and underserved communities are necessary and powerful ways to help progress health equity.
  4. Fostering a diverse healthcare workforce: To encourage youth from historically marginalized communities to pursue a career in healthcare, there is a need to create a pipeline that reaches them at an earlier stage and provides preparation programs attuned to their needs. It is crucial to emphasize the importance of individual identity and background in shaping one’s experiences to create a stronger, more diverse workforce that can meet the needs of diverse patient populations.
Image of Francisco Pancho Arguelles
“Build a base that is rooted in the leadership and the wisdom of the people who are navigating that suffering.”

— Francisco (Pancho) Arguelles, Senior Director for Network and Power Building, The Praxis Project

“Always lead and move at the speed of trust. Being authentic with your voice and being intentional is about having that equitable lens in every place that you have the privilege to speak.”

— Rita Carreón, Vice President for Health, UnidosUS

Image of Rita Carreon

Moving forward, The Collective and its partners will continue these discussions and take actions that contribute to advancing health equity. Following the 2022 Health Equity in Action Summit, more than 30 partners and members of The Collective developed An Action Guide to Disrupt Inequitable Health Outcomes, a community-led tool that provides cases, actionable steps, and practical resources for all aiming to move the needle on health equity. This guide serves as a continued source of validation for what can be accomplished together. As a living document, attendees have discussed ways to build on the Action Guide, such as including new resources to help ensure that the increased use of AI does not widen the gap in health outcomes for marginalized communities.

The Collective continues to collaborate across sectors and help advance multi-generational, sustainable change. The 2024 Summit is just one step in the journey to help push forth health equity for all and sustain the community moving forward.

To continue Summit discussions, watch the session recordings here.

Carousel1_600x450.webp
Carousel2_600x450.webp
Carousel3_600x450.webp
Carousel4_600x450.webp
Carousel5_600x450.webp
Carousel6_600x450.webp

Related Topics:

  • https://www.pfizer.com/news/articles/pfizers_multicultural_health_equity_collective_marks_10_years_of_progress
  • https://www.pfizer.com/news/announcements/pfizer-awards-2m-nonprofit-organizations-addressing-systemic-health-inequities
  • https://www.pfizer.com/about/responsibility/global-impact/multicultural-health-equity-collective
Share
April Social Media Round-Up—Trailblazer Cancer Research Grants, World Health Day, and More

April has come to a close and we are barreling towards the summer. Before you head outside to enjoy spring, take a moment to catch up with Pfizer’s social channels, which have been on fire. Check out updates across our channels.

April Social Media Round-Up—Trailblazer Cancer Research Grants, World Health Day, and More

April has come to a close and we are barreling towards the summer. Before you head outside to enjoy spring, take a moment to catch up with Pfizer’s social channels, which have been on fire. Check out updates across our channels.

CEO Albert Bourla Reflects on Pfizer’s Year of Bold Moves and Relentless Innovation in 2025 Annual Review

2025 was a typically busy year for Pfizer, one of strong performance, disciplined execution and bold moves that position us for future growth and lasting impact for patients around the world as we continue to pursue our mission of making breakthroughs that change people’s lives.

CEO Albert Bourla Reflects on Pfizer’s Year of Bold Moves and Relentless Innovation in 2025 Annual Review

2025 was a typically busy year for Pfizer, one of strong performance, disciplined execution and bold moves that position us for future growth and lasting impact for patients around the world as we continue to pursue our mission of making breakthroughs that change people’s lives.

One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options

Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.

One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options

Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.

Hiding in Plain Sight: The Racial Toll of Lyme Disease

Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.

Hiding in Plain Sight: The Racial Toll of Lyme Disease

Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.

Pfizer Enters into Agreement with Walgreens to Help Eligible U.S. Adults Navigate Their Healthcare Journey

For some adults, keeping up with their health, including understanding which vaccinations they may be eligible to receive, may feel like a daunting task. The agreement between Pfizer and Walgreens is intended to help make the process more connected and personal.

Pfizer Enters into Agreement with Walgreens to Help Eligible U.S. Adults Navigate Their Healthcare Journey

For some adults, keeping up with their health, including understanding which vaccinations they may be eligible to receive, may feel like a daunting task. The agreement between Pfizer and Walgreens is intended to help make the process more connected and personal.

April Social Media Round-Up—Trailblazer Cancer Research Grants, World Health Day, and More

April has come to a close and we are barreling towards the summer. Before you head outside to enjoy spring, take a moment to catch up with Pfizer’s social channels, which have been on fire. Check out updates across our channels.

April Social Media Round-Up—Trailblazer Cancer Research Grants, World Health Day, and More

April has come to a close and we are barreling towards the summer. Before you head outside to enjoy spring, take a moment to catch up with Pfizer’s social channels, which have been on fire. Check out updates across our channels.

CEO Albert Bourla Reflects on Pfizer’s Year of Bold Moves and Relentless Innovation in 2025 Annual Review

2025 was a typically busy year for Pfizer, one of strong performance, disciplined execution and bold moves that position us for future growth and lasting impact for patients around the world as we continue to pursue our mission of making breakthroughs that change people’s lives.

CEO Albert Bourla Reflects on Pfizer’s Year of Bold Moves and Relentless Innovation in 2025 Annual Review

2025 was a typically busy year for Pfizer, one of strong performance, disciplined execution and bold moves that position us for future growth and lasting impact for patients around the world as we continue to pursue our mission of making breakthroughs that change people’s lives.

One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options

Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.

One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options

Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.

Hiding in Plain Sight: The Racial Toll of Lyme Disease

Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.

Hiding in Plain Sight: The Racial Toll of Lyme Disease

Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.

Pfizer Enters into Agreement with Walgreens to Help Eligible U.S. Adults Navigate Their Healthcare Journey

For some adults, keeping up with their health, including understanding which vaccinations they may be eligible to receive, may feel like a daunting task. The agreement between Pfizer and Walgreens is intended to help make the process more connected and personal.

Pfizer Enters into Agreement with Walgreens to Help Eligible U.S. Adults Navigate Their Healthcare Journey

For some adults, keeping up with their health, including understanding which vaccinations they may be eligible to receive, may feel like a daunting task. The agreement between Pfizer and Walgreens is intended to help make the process more connected and personal.

Pfizer: One of the world’s premier biopharmaceutical companies
  • Investors
  • Media
  • Careers
  • Partners
  • PfizerForAll
  • Healthcare Professionals
  • Grant Seekers
  • Business to Business
  • Privacy Statement
  • Accessibility Statement
  • Terms of Use
  • Contact Us

Glossary

  • © 2026 Pfizer Inc. All rights reserved

This information—including product information—is intended only for residents of the United States.

The products discussed herein may have different labeling in different countries.

 

  • Twitter
  • Facebook
  • Linked In
  • Instagram
  • Youtube